GlassScriptPhysician profile
Swarup Swaminathan
NPI 1316357825
$60,558.84
in general payments reported to CMS, 2019-2025
16 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2020: $3,779 · 2021: $2,877 · 2022: $26K · 2023: $6,364 · 2024: $3,892 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Food and Beverage: $1,946 · Travel and Lodging: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,450.00 |
| Food and Beverage | $1,946.34 |
| Travel and Lodging | $756.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $47,585.17 | 2022-2025 | Durysta, Xen Glaucoma Treatment System, Lumigan |
| Sight Sciences, INC. | $3,985.70 | 2019-2024 | Omni Surgical System |
| Ivantis, INC | $2,645.56 | 2020-2021 | |
| Topcon Healthcare, INC. | $2,000.00 | 2022 | |
| Alcon Vision LLC | $1,326.76 | 2019-2024 | Argos, Clareon, Centurion |
| Allergan, INC. | $979.78 | 2019-2022 | |
| Heidelberg Engineering, INC. | $811.65 | 2020-2022 | |
| New World Medical,INC. | $247.52 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $243.98 | 2019-2021 | |
| Glaukos Corporation | $163.37 | 2025 | Idosetr |
| Horizon Therapeutics Plc | $142.86 | 2023 | Tepezza |
| Rxsight INC | $128.00 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $115.87 | 2019 | |
| Bausch & Lomb Americas INC. | $99.78 | 2022 | |
| Carl Zeiss Meditec, INC. | $57.55 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $25.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swarup Swaminathan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.